Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,628
Recruiting: 1,398
Ph III recruiting: 152
Growth YoY: +22.4%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05420467	A Study for the Adjuvant Treatment of Breast Cancer	recruiting	Phase 4	2,413	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Jul 1, 2022	clinicaltrials
NCT04929548	Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP	not yet recruiting	Phase 4	20	Wuhan UniversityOTHER	0	Jan 5, 2022	clinicaltrials